Characterization of the gelatinase system of the laminar human optic nerve, and surrounding annulus of bruch's membrane, choroid, and sclera

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 4, 2014, Pages 2358-2364

  Hussain, Ali A ^a   Lee, Yunhee ^a   Zhang, Jin Jun ^a   Marshall, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glaucoma; Matrix metalloproteinases; Optic nerve

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; ASTROCYTE; BRUCH MEMBRANE; ENZYME ASSAY; EXTRACELLULAR MATRIX; EYE FUNDUS; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; OPTIC NERVE; PLASTICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; ZYMOGRAPHY;

GLAUCOMA; MATRIX METALLOPROTEINASES; OPTIC NERVE;

AGED; AGING; BRUCH MEMBRANE; CHOROID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GELATINASES; HUMANS; MIDDLE AGED; OPTIC NERVE; SCLERA;

EID: 84898872447     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12503     Document Type: Article

References (63)

1. Burgoyne CF, Downs JC. Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behaviour of the aged optic nerve head. J Glaucoma. 2008;17:318-328.
2. Anderson DR. Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol. 1969;82: 800-814.
3. Emery JM, Landis D, Paton D, Boniuk M, Craig JM. The lamina cribrosa in normal and glaucomatous human eyes. Trans Am Acad Ophthalmol Otolaryngol. 1974;782:OP290-OP297.
4. Roberts MD, Grau V, Grimm J, et al. Remodelling of the connective tissue microarchitecture of the lamina cribrosa in early experimental glaucoma. Invest Ophthalmol Vis Sci. 2009;50:681-690.
5. Hernandez MR. Ultrastructural immunocytochemical analysis of elastin in the human lamina cribrosa. Changes in elastic fibers in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1992;33:2891-2903.
6. Hernandez M. The optic nerve head in glaucoma: Role of astrocytes in tissue remodelling. Prog Retin Eye Res. 2000;19: 297-321.
7. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumour necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol. 2000;118:666-673.
8. Agapova OA, Ricard CS, Salvador-Silva M, Hermandez MR. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia. 2001;33:205-216.
9. Hernandez MR, Luo XX, Andrzejewska W, et al. Age-related changes in the extracellular matrix of the human optic nerve head. Am J Ophthalmol. 1989;107:476-484.
10. Morrison JC, Jerdan JA, Dorman ME, et al. Structural proteins of the neonatal and adult lamina cribrosa. Arch Ophthalmol. 1989;107:1220-1224.
11. Albon J, Karwatowski WSS, Avery N, Easty DL, Duance VC. Changes in the collagenous matrix of the aging human lamina cribrosa. Brit J Ophthalmol. 1995;79:368-375.
12. Hernandez MR, Luo XX, Igoe F, Neufeld AH. Extracellular matrix of the human lamina cribrosa. Am J Ophthalmol. 1987; 104:567-576.
13. Hernandez MR, Wang N, Hanley NM, et al. Localization of collagen types I and IV mRNAs in human optic nerve head by in situ hybridization. Invest Ophthalmol Vis Sci. 1991;32: 2169-2177.
14. Tezel G, Luo C, Yang X. Accelerated aging in glaucoma: Immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci. 2007;48:1201-1211.
15. Amano S, Kaji Y, Oshika T, et al. Advanced glycation end products in human optic nerve head. Br J Ophthalmol. 2001; 85:52-55.
16. Bailey AJ, Paul RG, Knott L. Mechanism of maturation and aging of collagen. Mech Ageing Dev. 1998;106:1-56.
17. Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of ageing. Drugs Aging. 1996;9:69-77.
18. Albon J, Karwatowski WS, Easty DL, et al. Age related changes in the non-collagenous components of the extracellular matrix of the human lamina cribrosa. Br J Ophthalmol. 2000;84:311-317.
19. Kotecha A, Izadi S, Jeffery G. Age related changes in the thickness of the human lamina cribrosa. Br J Ophthalmol. 2006;90:1531-1534.
20. Sigal IA, Flanagan JG, Tertinegg I, Ethier CR. Finite element modelling of optic nerve head biomechanics. Invest Ophthalmol Vis Sci. 2004;45:4378-4387.
21. Downs JC, Suh JKF, Thomas KA, Bellezza AJ, Burgoyne CF, Hart RT. Viscoelastic characterization of peripapillary sclera: material properties by quadrant in rabbit and monkey eyes. J Biomech Eng. 2003;125:124-131.
22. Friberg TR, Lace JW. A comparison of the elastic properties of human choroid and sclera. Exp Eye Res. 1988;47:429-436.
23. Yang H, Downs JC, Girkin C, et al. 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: lamina cribrosa and peripapillary scleral position and thickness. Invest Ophthalmol Vis Sci. 2007;48:4597-4607.
24. Quigley HA, Addicks EM, Green WR, et al. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99:635-649.
25. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology. 1979;86:1803-1830.
26. Bellezza AJ, Rintalan CJ, Thompson HW, et al. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci. 2003;44: 623-637.
27. Burgoyne CF, Downs JC, Bellezza AJ, et al. Three-dimensional reconstruction of normal and early glaucoma monkey optic nerve head connective tissues. Invest Ophthalmol Vis Sci. 2004;45:4388-4399.
28. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci. 2005;46:175-182.
29. Pena JD, Taylor AW, Ricard CS, Vidal I, Hernandez MR. Transforming growth factor beta isoforms in human optic nerve heads. Br J Ophthalmol. 1999;83:209-218.
30. Girard MJ, Suh JK, Bottlang M, Burgoyne CF, Downs JC. Scleral biomechanics in the aging monkey eye. Invest Ophthalmol Vis Sci. 2009;50:5226-5237.
31. Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res. 2005;24:39-73.
32. Minckler DS, Spaeth GL. Optic nerve damage in glaucoma. Surv Ophthalmol. 1981;26:128-148.
33. Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969;53:721-748.
34. Fechtner RD, Weinreb RN. Mechanisms of optic nerve head damage in primary open-angle glaucoma. Surv Ophthalmol. 1994;39:23-42.
35. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodelling. Prog Retin Eye Res. 2000;19: 297-321.
36. Downs JC, Roberts MD, Burgoyne CF. Mechanical environment of the optic nerve head in glaucoma. Optom Vis Sci. 2008;85: 425-435.
37. Miller KN, Quigley HA. The clinical appearance of the lamina cribrosa as a function of the extent of glaucomatous optic nerve damage. Ophthalmology. 1988;95:135-138.
38. Fariss RN, Apte SS, Luthert PJ, Bird AC, Milam AH. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol. 1998;82:1329-1334.
39. Klenotic PA, Munier FL. Marmorstein LY, Apte BA. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein1 (EFEMP1). J Biol Chem. 2004;279:30469-30473.
40. Marmorstein LY, Munier FL, Arsenijevic Y, et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:13067-13072.
41. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res. 2001;64: 523-532.
42. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 1991;5:2145-2154.
43. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455-463.
44. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit. Rev Oral Biol Med. 1993;4: 197-250.
45. Hussain AA, Lee Y, Zhang JJ, Marshall J. Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci. 2011;52:4459-4466.
46. Kumar A, El-Osta A, Hussain AA, Marshall J. Increased sequestration of matrix metalloproteinases in ageing human Bruch's membrane: implications for ECM turnover. Invest Ophthalmol Vis Sci. 2010;51:2664-2670.
47. Hussain AA, Lee Y, Marshall J. High molecular-weight gelatinase species of human Bruch's membrane: compositional analyses and age-related changes. Invest Ophthalmol Vis Sci. 2010;51:2363-2371.
48. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci. 1999;40:2676-2682.
49. Lowry OH, Roseborough NJ, Farr et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
50. Karwatowski WSS, Jefferies TE, Duance VC, Albon J, Bailey AJ Easty DL. Preparation of Bruch's membrane and analysis of the age related changes in the structural collagens. Brit J Ophthalmol. 1995;79:944-952.
51. Drance SM, Sweeney VP, Morgan RW, et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89:457-465.
52. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621-664.
53. Goldberg I, Hollows FC, Kass MA, et al. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol. 1981; 65:56-62.
54. Quigley HA, Dorman-Pease ME, Brown AE. Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma. Curr Eye Res. 1991;10:877-888.
55. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
56. Yamada Y, Ishibashi K, Ishibashi, K, et al. The expression of advanced glycation endproduct receptors in RPE cells associated with basal deposits in human maculas. Exp Eye Res. 2006;82:840-848.
57. Mott JD, Khalifah RG, Nagase H, Shield CF, Hudson JK, Hudson BG. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int. 1997;52:1302-1312.
58. Hamlin CR, Kohn RR. Evidence for progressive, age-related structural changes in post-mature human collagen. Biochim Biophys Acta. 1971;236:458-467.
59. Vater CA, Harris ED, Siegel RE. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J. 1979;181:639-645.
60. Tezel G, Hermandez MR, Wax MB. In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head. Glia. 2001;34:178-189.
61. Kirwan RP, Crean JK, Fenerty CH, Clark AF, O'Brien CJ. Effect of cyclical mechanical stretch and exogenous transforming growth factor-b1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head. J Glaucoma. 2004;13:327-334.
62. Pena J. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy. Exp Eye Res. 1998;67:517-524.
63. Spoerl E, Boehm AG, Pillunat LE. The influence of various substances on the biochemical behaviour of lamina cribrosa and peripapillary sclera. Invest Ophthalmol Vis Sci. 2005;46: 1286-1290.